CD4+ T cells mediate antibody-independent acquired immunity to pneumococcal colonization

被引:274
作者
Malley, R
Trzcinski, K
Srivastava, A
Thompson, CM
Anderson, PW
Lipsitch, M
机构
[1] Childrens Hosp, Div Infect Dis, Dept Med, Boston, MA 02115 USA
[2] Harvard Univ, Sch Med, Boston, MA 02115 USA
[3] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02215 USA
[4] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02215 USA
[5] Univ Rochester, Dept Pediat, Rochester, NY 14627 USA
关键词
Streptococcus pneumoniae; cell-mediated immunity; vaccine;
D O I
10.1073/pnas.0501254102
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Acquired immunity to Streptococcus pneumoniae (pneumococcus) has long been assumed to depend an the presence of anticapsular antibodies. We found, however, that colonization with live pneumococci of serotypes 6B, 7F, or 14 protected mice against recolonization by any of the serotypes and that protection from acquisition of a heterologous or homologous strain did not depend on anticapsular antibody. Further, intranasal immunization by live pneumococcal colonization or by a killed, nonencapsulated whole-cell vaccine protected antibody-deficient mice against colonization, suggesting independence of antibodies to any pneumococcal antigens. Protection by intranasal immunization with whole-cell vaccine was completely abrogated in T cell-deficient mice, and in mice that were congenitally deficient in CD4(+) T cells or depleted of these cells at the time of challenge. In contrast, mice congenitally deficient in, or depleted of, CD8(+) T cells were fully protected. Protection in this model was observed beyond 2 months after immunization, arguing against innate or nonspecific immune mechanisms. Thus, we find that immunity to pneumococcal colonization can be induced in the absence of antibody, independent of the capsular type, and this protection requires the presence of CD4(+) T cells at the time of challenge.
引用
收藏
页码:4848 / 4853
页数:6
相关论文
共 36 条
[1]   Cutting edge: Different toll-like receptor agonists instruct dendritic cells to induce distinct th responses via differential modulation of extracellular signal-regulated kinase-mitogen-activated protein kinase and c-fos [J].
Agrawal, S ;
Agrawal, A ;
Doughty, B ;
Gerwitz, A ;
Blenis, J ;
Van Dyke, T ;
Pulendran, B .
JOURNAL OF IMMUNOLOGY, 2003, 171 (10) :4984-4989
[2]   Streptococcus pneumonia capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory [J].
Åhman, H ;
Käyhty, H ;
Lehtonen, H ;
Leroy, O ;
Froeschle, J ;
Eskola, J .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1998, 17 (03) :211-216
[3]   IMMUNIZATION OF 2-MONTH-OLD INFANTS WITH PROTEIN-COUPLED OLIGOSACCHARIDES DERIVED FROM THE CAPSULE OF HEMOPHILUS-INFLUENZAE TYPE-B [J].
ANDERSON, P ;
PICHICHERO, ME ;
INSEL, RA .
JOURNAL OF PEDIATRICS, 1985, 107 (03) :346-351
[4]  
[Anonymous], 1998, Wkly Epidemiol Rec, V73, P187
[5]   SOME ASPECTS OF THE PNEUMOCOCCAL CARRIER STATE [J].
AUSTRIAN, R .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1986, 18 :35-45
[6]   Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children [J].
Black, S ;
Shinefield, H ;
Fireman, B ;
Lewis, E ;
Ray, P ;
Hansen, JR ;
Elvin, L ;
Ensor, KM ;
Hackell, J ;
Siber, G ;
Malinoski, F ;
Madore, D ;
Chang, I ;
Kohberger, R ;
Watson, W ;
Austrian, R ;
Edwards, K .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2000, 19 (03) :187-195
[7]   Pneumococcal diversity: Considerations for new vaccine strategies with emphasis on pneumococcal surface protein A (PspA) [J].
Briles, DE ;
Tart, RC ;
Swiatlo, E ;
Dillard, JP ;
Smith, P ;
Benton, KA ;
Ralph, BA ;
Brooks-Walter, A ;
Crain, MJ ;
Hollingshead, SK ;
McDaniel, LS .
CLINICAL MICROBIOLOGY REVIEWS, 1998, 11 (04) :645-+
[8]   STREPTOCOCCUS-PNEUMONIAE ANCHOR TO ACTIVATED HUMAN-CELLS BY THE RECEPTOR FOR PLATELET-ACTIVATING-FACTOR [J].
CUNDELL, DR ;
GERARD, NP ;
GERARD, C ;
IDANPAANHEIKKILA, I ;
TUOMANEN, EI .
NATURE, 1995, 377 (6548) :435-438
[9]   Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine [J].
Dagan, R ;
Melamed, R ;
Muallem, M ;
Piglansky, L ;
Greenberg, D ;
Abramson, O ;
Mendelman, PM ;
Bohidar, N ;
Yagupsky, P .
JOURNAL OF INFECTIOUS DISEASES, 1996, 174 (06) :1271-1278
[10]  
de Jong R, 1998, SCIENCE, V280, P1435